US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even though the US Food and Drug Administration (FDA) previously gave the green light to the project – in a decision that could have…
Category: 6. Business
-
Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development
– Utilizing Ascletis’ Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady state, in…
Continue Reading
-
Chinese billionaire in talks to buy Netafim
Chinese billionaire Haoyu Wang is in talks to buy control of Israeli irrigation systems company Netafim from Mexico’s Orbia. Over the past year, Orbia has been in talks with various parties to sell its holdings in Netafim in order to reduce its…
Continue Reading
-
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) on February 09, 2026 in New York City.
Spencer Platt | Getty Images
Stock futures inched higher late Tuesday as traders looked ahead to the release of the delayed January jobs report.
Continue Reading
-
U.S. and Canada Chemistry Leaders Strengthen Responsible Care® through MOU
Washington, D.C., and Ottawa, Ontario (Feb. 10, 2025) – The American Chemistry Council (ACC) and the Chemistry Industry Association of Canada (CIAC) today renewed a…
Continue Reading
-
Asian Stocks Set to Extend Rally as US Shares Slip: Markets Wrap – Bloomberg.com
- Asian Stocks Set to Extend Rally as US Shares Slip: Markets Wrap Bloomberg.com
- Asia-Pacific markets set to climb as investors shrug off weak U.S. retail sales, eye China inflation CNBC
- Asian stocks set to extend rally as US shares slip Yahoo…
Continue Reading
-
Royal Caribbean Group Raises Dividend Fifty Percent
MIAMI, Feb. 10, 2026 /PRNewswire/ — The Board of Directors of Royal Caribbean Group (NYSE: RCL) today declared a quarterly dividend of $1.50 per common share payable on April…
Continue Reading
-
Ford says EV woes will continue to plague company despite writedown
Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Ford is struggling to stem the bleeding at its embattled electric vehicle division, even as it expects the profitability…
Continue Reading
-
FDA Approves Pembrolizumab Plus Paclitaxel With/Without Bevacizumab for PD-L1+ Platinum-Resistant Ovarian Cancer – OncLive
- FDA Approves Pembrolizumab Plus Paclitaxel With/Without Bevacizumab for PD-L1+ Platinum-Resistant Ovarian Cancer OncLive
- FDA Approves Pembrolizumab Combo for Recurrent Ovarian Cancer Targeted Oncology
- Keytruda Combo Approved for…
Continue Reading
-
Leading Global Power and Infrastructure Financial Institution MUFG Backs Fermi America™ with $500 Million Equipment Loan to Accelerate 11GW Private Energy Campus
- MUFG Boasts Deep Experience Supporting Large-Scale Energy Projects Worldwide
- Prepares Fermi America to Deliver on First 2.3GW of Power in Years Ahead
AMARILLO, Texas, Feb. 10, 2026 /PRNewswire/ — Fermi Inc. (d/b/a…
Continue Reading